Pharmaceuticals excipient is a substance added with an active ingredient during manufacturing process of a drug. It helps in long term stabilization, reduction of viscosity, and enhancement of solubility of a drug. The prevention of denaturation of active ingredient at the time of manufacturing process of drug is possible through excipients. It also enhances of taste & appearance of medicines. Pharmaceutical excipients help in transportation of drug to intended part of body and disintegration of drug into small particles to reach blood stream faster.
The growth of the global pharmaceuticals market and emergence of new excipients are factors that fuel the growth of the world pharmaceuticals excipients market. However, declining R&D investments and increased regulatory requirements leading to shortage of FDA-approved manufacturing sites. An advancement in nanotechnology and multi-functionality excipients are creating opportunities in the market.The world pharmaceutical excipients market is segmented based on products, functionality, routes of administration, and geography. The products covered in the report include organic and inorganic chemicals. On the basis of functionality, the market is classified into fillers, binders, lubricants, and preservatives. Oral, topical, parenteral, and others are routes of administration discussed in the report. The market is divided geographically into North America, Europe, Asia-Pacific, and Latin America, Middle East and Africa (LAMEA).
Some of the prominent players in this market are BASF SE, Ashland Inc., The Dow Chemical Company, Evonik Industries, Roquette, Colorcon Inc., FMC Corporation, Avantor Performance Materials Inc., and Lubrizol Corporation. Various strategies such as collaborations, expansions, joint ventures, acquisitions, and new product launches have helped these companies to strengthen their position in this competitive market.
KEY BENEFITS FOR STAKEHOLDERS:
KEY MARKET SEGMENTS:
KEY MARKET PLAYERS:
SIMILAR MARKET STUDIES
Summary Amgen Inc. (Amgen) is a biotechnology company. It undertakes the discovery, development, manufacture and commercialization of innovative human therapeutics. The company products are used in the treatment of cancer, rheumatoid arthritis, kidney disease, bone disease and many other serious illnesses. Amgen’s R&D organization has expertise in multiple treatment modalities, antibodies, ...
July 2016 | $250 | View Details >>
Summary Colby Pharmaceutical Company (CPC) is a pharmaceutical company that develops biologic and small molecule drugs for for cancer, infection, inflammation and pain. The companys products include CPC-410, CPC-507, CPC-703 and CPC-1001. CPCs CPC-410 is ? mitochondria-targeted drug, which is used in the treatment of metastatic radio-therapy-resistant and chemo-therapy-resistant tumors. The ...
July 2015 | $250 | View Details >>
The United States LHRH Analogs Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the LHRH Analogs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of ...
March 2017 | $3700 | View Details >>
The Global Orthopedic Soft Tissue Repair Device Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Orthopedic Soft Tissue Repair Device market. First, the report provides a basic overview of the Orthopedic Soft Tissue Repair Device industry including definitions, classifications, applications and industry ...
February 2016 | $4000 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research